公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
1994 | Characteristic clinicopathologic features of adult B‐cell lymphoblastic lymphoma with special emphasis on differential diagnosis with an atypical form probably of blastic lymphocytic lymphoma of intermediate differentiation origin | ANN-LII CHENG ; Su I.‐J.; HWEI-FANG TIEN ; Wang C.‐C.; YAO-CHANG CHEN ; Wang C.‐H. | Cancer | 18 | ||
1993 | Characteristic clinicopathologic features of epstein-barr virus—associated peripheral T-cell lymphoma | ANN-LII CHENG ; Ih-Jen Su; YAO-CHANG CHEN ; Wu-Ching Uen; Chiu-Hwa Wang | Cancer | 82 | ||
2010 | Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions | YU-YUN SHAO ; Hu F.-C.; JIN-TUNG LIANG ; Chiu W.-T.; ANN-LII CHENG ; CHIH-HSIN YANG | Journal of the Formosan Medical Association | 27 | 23 | |
1988 | Characterization of the spectrum of postthymic T‐cell malignancies in Taiwan a clinicopathologic study of HTLV‐1‐positive and HTLV‐1‐negative cases | Su I.-J.; Wang C.-H.; ANN-LII CHENG ; YAO-CHANG CHEN ; Hsieh H.-C.; HWEI-FANG TIEN ; Huang S.-S.; CHUNG-YI HU ; PEI-JER CHEN ; Chen J.-Y.; Hsu H.-C.; Chuang S.-M.; MING-CHING SHEN ; Kadin M.E. | Cancer | 45 | ||
2002 | The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells | Hergenhahn M.; Soto U.; Weninger A.; Polack A.; CHIH-HUNG HSU ; ANN-LII CHENG ; Rösl F. | Molecular Carcinogenesis | 70 | 61 | |
2017 | Chemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomas | WEI-LI MA ; MING YAO ; SHU-LANG LIAO ; JIH-LUH TANG ; Wang Y.-C.; SUNG-HSIN KUO ; ANN-LII CHENG | Oncotarget | 6 | 4 | |
2000 | Chemotherapy alone versus, surgery followed by chemotherapy for stage I/IIE large-cell lymphoma of the stomach | Liu H.-T.; CHIUN HSU ; Chen C.-L.; Chiang I.-P.; Chen L.-T.; YAO-CHANG CHEN ; ANN-LII CHENG | American Journal of Hematology | 34 | ||
2014 | Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study | CHIUN HSU ; Tsou H.-H.; Lin S.-J.; Wang M.-C.; MING YAO ; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; HWEI-FANG TIEN ; Liu T.-W.; PEI-JER CHEN ; ANN-LII CHENG | Hepatology | 227 | 210 | |
2014 | Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers | HSIANG-FONG KAO ; I-CHUN CHEN ; CHIUN HSU ; Chang S.-Y.; Chien S.-F.; YEE-CHUN CHEN ; Hu F.-C.; CHIH-HSIN YANG ; ANN-LII CHENG ; KUN-HUEI YEH | Supportive Care in Cancer | 10 | 10 | |
1996 | Chronic oral etoposide and tamoxifen in the treatment of far-advanced hepatocellular carcinoma | ANN-LII CHENG ; YAO-CHANG CHEN ; KUN-HUEI YEH ; Chuang S.-E.; Chen B.-R.; DING-SHINN CHEN | Cancer | 37 | ||
2010 | CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells | Chen K.-F.; Liu C.-Y.; Lin Y.-C.; Yu H.-C.; TSUNG-HAO LIU ; Hou D.-R.; PEI-JER CHEN ; ANN-LII CHENG | Oncogene | 148 | 139 | |
2012 | CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cells | Lin Y.-C.; Chen K.-C.; CHING-CHOW CHEN ; ANN-LII CHENG ; Chen K.-F. | Oral Oncology | 54 | 53 | |
1998 | Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL) - A very effective regimen with good patients' compliance for advanced gastric cancer | ANN-LII CHENG ; KUN-HUEI YEH ; Lin J.-T.; CHIUN HSU ; Liu M.-Y. | Anticancer Research | 23 | 20 | |
2014 | Clinical activity of metronomic chemotherapy in liver cancers | YU-YUN SHAO ; ANN-LII CHENG ; CHIH-HUNG HSU | Metronomic Chemotherapy: Pharmacology and Clinical Applications | 0 | 0 | |
2014 | Clinical characteristics of advanced hepatocellular carcinoma patients with prolonged survival in the era of anti-angiogenic targeted-therapy | LI-CHUN LU ; YU-YUN SHAO ; Chan S.-Y.; CHIH-HUNG HSU ; ANN-LII CHENG | Anticancer Research | 12 | 10 | |
2010 | Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma | Whang-Peng J.; ANN-LII CHENG ; CHIUN HSU ; Chen C.-M. | Journal of Experimental and Clinical Medicine | 25 | 0 | |
2020 | Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer | WEN-CHI YANG ; Feng-Ming Hsu ; YU-HSUAN CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU ; ZHONG-ZHE LIN ; Lu S.-H.; CHIH-HSIN YANG ; ANN-LII CHENG ; SUNG-HSIN KUO | Clinical and Translational Radiation Oncology | 11 | 8 | |
2016 | Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer | I-CHUN CHEN ; Chang Y.-C.; YEN-SHEN LU ; KUEI-PIN CHUNG ; CHIUN-SHENG HUANG ; TZU-PIN LU ; WEN-HUNG KUO ; Wang M.-Y.; KUAN-TING KUO ; Wu P.-F.; Hsueh T.-H.; Shen C.-Y.; CHING-HUNG LIN ; ANN-LII CHENG | Scientific Reports | 18 | 17 | |
2013 | Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation | CHING-HUNG LIN ; Liu J.M.; YEN-SHEN LU ; Lan C.; Lee W.-C.; KUAN-TING KUO ; Wang C.-C.; DWANG-YING CHANG ; CHIUN-SHENG HUANG ; ANN-LII CHENG | Journal of Clinical Pathology | 13 | 14 | |
2007 | Clinical studies with curcumin | CHIH-HUNG HSU ; ANN-LII CHENG | Advances in Experimental Medicine and Biology | 359 | 305 |